← Eichor
Study identifier: NCT06915441 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Lipid Infusions to Optimize Nutrition Trial

Condition: Bronchopulmonary Dysplasia · Neurodevelopmental Impairment  ·  Sponsor: The University of Texas Health Science Center, Houston

PhasePhase 2
Planned participants230
Who can joinAll sexes, 12 Hours to 28 Weeks
Healthy volunteersNo

About this study

The purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE or SOLE is more effective in minimizing pulmonary outcomes, neonatal morbidities, long-term morbidity and mortality, and improving discharge growth and Bayley Scales of Infant Development Fourth Edition (BSID-IV) neurodevelopmental assessment at two years

This description comes directly from the study's public registry record.

Talk to the study team

Lindsay F Holzapfel, MD, MS  ·  (713) 500-6422  ·  Lindsay.N.Fleig@uth.tmc.edu

Emily Stephens  ·  (713) 500-5734  ·  Emily.K.Stephens@uth.tmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The University of Texas Health Science Center at HoustonHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06915441